GSK, iTeos to develop cancer drug in up to $2 bln deal
Britain’s GlaxoSmithKline Plc (GSK.L) has agreed to pay up to $2 billion to iTeos Therapeutics Inc (ITOS.O) to develop and sell a potential cancer treatment together, the companies said on
Read More